Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases

Details for Australian Patent Application No. 2004264842 (hide)

Owner Lipid Sciences, Inc.

Inventors Maltais, Jo-Ann B.; Bellotti, Marc; Cham, Bill E.

Agent FB Rice

Pub. Number AU-B-2004264842

PCT Pub. Number WO2005/016246

Priority 10/601,656 20.06.03 US; 60/533,542 31.12.03 US; 60/542,947 09.02.04 US; 60/491,928 01.08.03 US

Parent 2001274382

Filing date 21 June 2004

Wipo publication date 24 February 2005

Acceptance publication date 10 January 2008

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 35/24 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Mucus

A61K 35/26 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Lymph

A61K 35/48 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Reproductive organs

A61K 39/002 (2006.01) Medicinal preparations containing antigens or antibodies - Protozoa antigens

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 39/215 (2006.01) Medicinal preparations containing antigens or antibodies - Coronaviridae, e.g. avian infectious bronchitis virus

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61L 2/00 (2006.01) Disinfection or sterilising

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/08 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/10 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/02 (2006.01) Antiparasitic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2005/016246 Priority application(s): WO2005/016246

10 January 2008 Application Accepted

  Published as AU-B-2004264842

8 May 2008 Standard Patent Sealed

6 August 2009 Assignment Registered

  Lipid Sciences, Inc. The patent has been assigned to Eli Lilly and Company

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004264847-Method and apparatus for ultrasonic imaging

2004264839-Improved intra-dermal delivery of biologically active agents